OtherArticle
PROGRESS CURVE ANALYSIS OF CYP1A2 INHIBITION; A MORE INFORMATIVE APPROACH TO THE ASSESSMENT OF MECHANISM-BASED INACTIVATION?
David A Fairman, Claire Collins and Sarah Chapple
Drug Metabolism and Disposition September 6, 2007, DOI: https://doi.org/10.1124/dmd.107.017236